Bacterial negativity and reactivation (relapse) of lepromatous outpatients under sulfone treatment.
D000284:Administration, Oral; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007918:Leprosy / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D008134:Long-Term Care; D008297:Male; D009166:Mycobacterium leprae / Q000302:isolation & purification*; D012189:Retrospective Studies; D012867:Skin / Q000473:pathology; D013223:Statistics as Topic; D013450:Sulfones / Q000008:administration & dosage*; D013997:Time Factors
D013450:Sulfones